Fred Andy Broadway III
2018
In 2018, Fred Andy Broadway III earned a total compensation of $1M as President, BioTel Heart at BioTelemetry, a 47% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $209,100 |
|---|---|
| Option Awards | $170,853 |
| Salary | $344,636 |
| Stock Awards | $258,594 |
| Other | $24,231 |
| Total | $1,007,414 |
Broadway received $344.6K in salary, accounting for 34% of the total pay in 2018.
Broadway also received $209.1K in non-equity incentive plan, $170.9K in option awards, $258.6K in stock awards and $24.2K in other compensation.
Rankings
In 2018, Fred Andy Broadway III's compensation ranked 9,175th out of 14,244 executives tracked by ExecPay. In other words, Broadway earned more than 35.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,175 out of 14,244 | 36th |
Division Services | 1,641 out of 2,377 | 31st |
Major group Health Services | 135 out of 218 | 38th |
Industry group Miscellaneous Health And Allied Services, Not | 18 out of 44 | 59th |
Industry Specialty Outpatient Facilities, Not Elsewhere Classified | 6 out of 15 | 60th |
Source: SEC filing on March 20, 2019.
Broadway's colleagues
We found four more compensation records of executives who worked with Fred Andy Broadway III at BioTelemetry in 2018.